Ad
Thursday, 5 October 2017
New Jersey sues Insys as opioid maker settles with Massachusetts
BOSTON (Reuters) - New Jersey on Thursday accused Insys Therapeutics Inc of engaging a fraudulent scheme to boost sales of a fentanyl-based cancer pain drug, as Massachusetts announced a $500,000 settlement with the drugmaker to resolve similar allegations.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment